Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

FTSE 100 turns around on AstraZeneca jump, weaker pound

Published 30/03/2020, 08:36
Updated 30/03/2020, 17:50
© Reuters. FILE PHOTO: Signage is seen outside the entrance of the London Stock Exchange in London

By Sruthi Shankar and Devik Jain

(Reuters) - The UK's exporter-heavy FTSE 100 closed higher on Monday, helped by a jump in AstraZeneca's shares and a weaker pound, but the prospect of a prolonged coronavirus-led shutdown in Britain weighed on midcap shares.

The FTSE 100 index (FTSE) rose 1%, recovering from early losses as AstraZeneca (L:AZN) gained 4.4% after U.S. regulators approved its treatment against an aggressive type of lung cancer in previously untreated patients.

A weaker pound following a Fitch's cut to Britain's sovereign debt rating also helped the big dollar earners on the index.

However, the general mood was that of caution as investors were left wondering if the massive steps taken by policymakers over the pat weeks will be enough to shield global growth as many economists warn of a sharp economic slump.

The FTSE midcap index (FTMC) fell 1%, with shopping centre operator Hammerson (L:HMSO) sliding 22% to the bottom after it suspended its final dividend and said the outbreak would have a material impact on its earnings.

Adding to woes for domestic businesses, a senior medical officer said on Sunday some lockdown measures in Britain could last months and only be gradually lifted.

"I think the markets want to have hope, but the reality is there is still more pain to come in the short-term," said Louise Kernohan, investment director for UK Equities at Aberdeen Standard Investments.

The U.S. government passed a $2 trillion coronavirus relief bill last week, while the UK government's commitment to pay 80% of the wages of workers who are temporarily laid off, and monetary policy easing by major central banks, had sparked a bounce in global stocks last week.

Still, the FTSE 100 is still headed for its worst month in more than three decades and is down about 28% since hitting a peak in January.

Shares in aerospace suppliers Rolls-Royce (L:RR), Meggitt (L:MGGT) and Senior (L:SNR) fell between 12% and 14% after another bearish call from JPMorgan (NYSE:JPM).

The U.S. bank, which assumes a 38% drop in global air traffic in 2020, cut earnings estimates for the sector, and expects credit rating firms including the S&P to downgrade Rolls-Royce to non-investment grade.

Travel stocks have taken a beating, as the fast-spreading coronavirus triggered lockdowns globally, forcing airlines, and cruise and travel operators to scramble for cash to survive.

The wider travel and leisure index (FTNMX5750) fell 1.6%, with low-cost airline easyJet (L:EZJ) sliding 7.2% after revealing it had grounded its entire fleet and furloughed cabin crew for two months under a government job retention scheme.

"Within each sector, there will be relative winners and relative losers. The investors' job now is to choose the ones that will survive and hopefully will come out stronger after this - based on liquidity and balance sheet," said Aberdeen's Kernohan.

© Reuters. FILE PHOTO: Signage is seen outside the entrance of the London Stock Exchange in London

Battered shares in BP (L:BP) and Royal Dutch Shell (L:RDSa) gained even as Brent crude plunged to its cheapest in 18 years on fears about the economic hit from the pandemic as well as a price war between Russia and Saudi Arabia. [O/R]

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.